BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12522529)

  • 1. The role of TGF-beta in digestive organ disease.
    Takenoshita S; Fukushima T; Kumamoto K; Iwadate M
    J Gastroenterol; 2002; 37(12):991-9. PubMed ID: 12522529
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gastrointestinal peptides. Their importance in digestive physiology and pathology].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(4):297-312. PubMed ID: 2894049
    [No Abstract]   [Full Text] [Related]  

  • 3. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
    Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease.
    Rane SG; Lee JH; Lin HM
    Cytokine Growth Factor Rev; 2006; 17(1-2):107-19. PubMed ID: 16257256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.
    Pines M
    World J Gastroenterol; 2014 Oct; 20(40):14778-86. PubMed ID: 25356039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1 and disorders of the lung.
    Camoretti-Mercado B; Solway J
    Cell Biochem Biophys; 2005; 43(1):131-48. PubMed ID: 16043890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
    Levy L; Hill CS
    Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta signalling in brain disorders.
    Vivien D; Ali C
    Cytokine Growth Factor Rev; 2006; 17(1-2):121-8. PubMed ID: 16271500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
    Javelaud D; Mauviel A
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.
    Li M; Becnel LS; Li W; Fisher WE; Chen C; Yao Q
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):381-7. PubMed ID: 16314822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Smad3-dependent TGF-beta signal in vascular response to injury.
    Yokote K; Kobayashi K; Saito Y
    Trends Cardiovasc Med; 2006 Oct; 16(7):240-5. PubMed ID: 16980181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the aryl hydrocarbon receptor and transforming growth factor-beta signaling pathways: evidence of an asymmetrical relationship in rat granulosa cells.
    Bussmann UA; Barañao JL
    Biochem Pharmacol; 2008 Oct; 76(9):1165-74. PubMed ID: 18786509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF beta signalling and its role in tumour pathogenesis.
    Kaminska B; Wesolowska A; Danilkiewicz M
    Acta Biochim Pol; 2005; 52(2):329-37. PubMed ID: 15990918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.
    Haag SM; Hauck EW; Szardening-Kirchner C; Diemer T; Cha ES; Weidner W; Eickelberg O
    Eur Urol; 2007 Jan; 51(1):255-61. PubMed ID: 16782264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon.
    Roussa E; Wiehle M; Dünker N; Becker-Katins S; Oehlke O; Krieglstein K
    Stem Cells; 2006 Sep; 24(9):2120-9. PubMed ID: 16741229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta in cutaneous melanoma.
    Javelaud D; Alexaki VI; Mauviel A
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models.
    Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):335-41. PubMed ID: 18290874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.